Vulnpedia
← All CVEs

CVE-2026-105177

MEDIUM 5.1

Published 2026-10-05 · Last modified 2026-10-05

A vulnerability was identified in SourceCodester Drug Recommendation System 1.0. The affected element is an unknown function of the file /Admin/add_drug.php of the component Drug Creation. Such manipulation of the argument txtname/cmdtype/txtusage/txtsideeffect/cmdcontraindication leads to sql injection. The attack may be performed from remote. The exploit is publicly available and might be used.

NO EXPLOITATION SIGNALS

No known exploitation, public exploit, or elevated probability at this time. Track for changes.

Exploitation likelihood

0.3%chance of exploitation in 30 days · 23rd percentile

○ In CISA KEV ○ Public exploit / PoC

Impact if exploited

5.1CVSS 4.0 · MEDIUM

  • ConfidentialityLow
  • IntegrityLow
  • AvailabilityLow

What an attacker needs

  • ✓Access: Reachable over the network — no local access needed
  • ⚠Privileges: Requires an admin / high-privilege account
  • ✓User interaction: No user interaction needed
  • ✓Complexity: No special conditions — reliably repeatable
  • ✓Requirements: No special attack requirements

✓ lowers the bar for an attacker · ⚠ raises it

Proof of concept & exploit code

Test against your own equipment

curl -s https://vulnpedia.com/cve/CVE-2026-105177/poc.jsonMachine-readable PoC index for this CVE (for automation).

Listed for defensive triage, patch verification, and authorized testing on systems you own. Machine-readable: /cve/CVE-2026-105177/poc.json

Affected

Vendors Sourcecodester

Products Drug Recommendation System

Weakness (CWE)

  • CWE-89: SQL Injection
  • CWE-74: Injection

CVSS vector

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P

All CVSS metrics

  • MEDIUM 5.1 v4.0 · CNA Primary
    CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P
  • MEDIUM 4.7 v3.1 · CNA Primary
    CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L/E:P/RL:X/RC:R
  • MEDIUM 4.7 v3.0 · CNA Primary
    CVSS:3.0/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L/E:P/RL:X/RC:R
  • MEDIUM 5.8 v2.0 · CNA Primary
    AV:N/AC:L/Au:M/C:P/I:P/A:P/E:POC/RL:ND/RC:UR
  • LOW 2 v4.0 · NVD Secondary
    CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
  • MEDIUM 4.7 v3.1 · NVD Secondary
    CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
  • MEDIUM 5.8 v2.0 · NVD Secondary
    AV:N/AC:L/Au:M/C:P/I:P/A:P

References

Advisories

Technical & other

Sources: NVD · CVE.org · EPSS